Biosynthesis of preparing nicotinamide mononucleotide and derivatives thereof
OwnerYi Heng Percival ZHANGinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerYi Heng Percival ZHANGinventor
Estimating the term…
A method of making nicotinamide mononucleotide (NMN), nicotinamide mononucleotide derivatives, or mixtures thereof is disclosed. The method involves the in vitro artificial enzymatic pathways comprised: the generation of alpha-D-ribose-1-phosphate from numerous substrates followed by the synthesis of nicotinamide mononucleotide catalyzed by nicotinamide riboside phosphorylase and nicotinamide riboside kinase or the generation of 5-phospho-alpha-D-ribose-1-diphosphate from nucleotides followed by the synthesis of nicotinamide mononucleotide catalyzed by nicotinamide phosphoribosyltransferase. The multiple enzymes were reconstituted in one pot, wherein in-situ removal of byproducts that can be converted to other non-inhibitory chemicals with supplementary enzymes push the overall biotransformation toward the synthesis of nicotinamide mononucleotide. Furthermore, nicotinamide mononucleotide can be converted to its derivatives—nicotinamide adenine dinucleotide and nicotinamide adenine dinucleotide phosphate.
A method of making nicotinamide mononucleotide (NMN), NMN derivatives, or a mixture thereof, comprising generating a multi-enzyme reaction by mixing in an aqueous solution:
A method of making nicotinamide mononucleotide (NMN), NMN derivatives, or a mixture thereof, comprising generating a multi-enzyme reaction by mixing in an aqueous solution:
Dependencies are inferred from the claim text.